.FDA declines experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Permit MDMA Therapy, Looking For Even More Research The New York City TimesFDA Declines Ecstasy-Based Medicine The Exchange JournalFDA declines to accept unfamiliar MDMA treatment to handle post-traumatic stress disorder, with ask for additional hearing records CNNFDA rejects first psychedelic to alleviate PTSD, requiring more research study The Washington Message.